Clinical Radiology
Volume 62, Issue 7 , Pages 668-675 , July 2007

Application of percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatocellular carcinoma using microbubble contrast agent

Received 15 July 2006 ,Revised 13 November 2006 ,Accepted 21 November 2006.

References 

  1. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology. 1992;15:948–963
  2. Okuda K. Hepatocellular carcinoma. J Hepatol. 2000;32:S225–S237
  3. Bruix J, Sherman M, Llovet J, et al. EASL panel of experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference. J Hepatol. 2001;35:421–430
  4. Nino-Murcia M, Olcott EW, Jeffrey RB, et al. Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT. Radiology. 2000;215:746–751
  5. Ebara M, Ohto M, Sugiura N, et al. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol. 1990;5:616–626
  6. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer. 1992;69:925–929
  7. Lencioni R, Bartolozzi C, Caramella D, et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: analysis of prognostic factors in 105 Western patients. Cancer. 1995;76:1737–1746
  8. Goldberg SN, Gazelle GS, Solbiati L, et al. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol. 1996;3:636–644
  9. Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology. 1997;205:367–373
  10. Ryu M, Shimamura Y, Kinoshita T, et al. Therapeutic results of resection, transcatheter arterial embolization and percutaneous ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol. 1997;27:251–257
  11. Ebara M, Okabe S, Kita K, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol. 2005;43:458–464
  12. Takayasu K, Muramatsu Y, Asai S, et al. CT fluoroscopy-assisted needle puncture and ethanol injection for hepatocellular carcinoma: a preliminary study. AJR Am J Roentgenol. 1999;173:1219–1224
  13. Sato M, Watanabe Y, Tokui K, et al. CT-guided treatment of ultrasonically invisible hepatocellular carcinoma. Am J Gastroenterol. 2000;95:2102–2106
  14. Schweiger GD, Brown BP, Pelsang RE, et al. CT fluoroscopy: technique and utility in guiding biopsies of transiently enhancing hepatic masses. Abdom Imaging. 2000;25:81–85
  15. Shibata T, Iimuro Y, Yamamoto Y, et al. CT-guided transthoracic percutaneous ethanol injection for hepatocellular carcinoma not detected with US. Radiology. 2002;223:115–120
  16. Kirchner J, Kickuth R, Laufer U, et al. CT fluoroscopy-assisted puncture of thoracic and abdominal masses: a randomized trial. Clin Radiol. 2002;57:188–192
  17. Solomon SB, Bohlman ME, Choti MA. Percutaneous gadolinium injection under MR guidance to mark target for CT-guided radiofrequency ablation. J Vasc Interv Radiol. 2002;13:419–421
  18. Adam A, Hatzidakis A, Hamady M, et al. Percutaneous coil placement prior to radiofrequency ablation of poorly visible hepatic tumors. Eur Radiol. 2004;14:1688–1691
  19. Bartolozzi C, Lencioni R, Ricci P, et al. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US. Radiology. 1998;209:387–393
  20. Solbiati L, Goldberg SN, Ierace T, et al. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent—early experience. Radiology. 1999;211:643–649
  21. Blomley MJ, Albrecht T, Cosgrove DO, et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SHU 508A: early experience. Radiology. 1999;210:409–416
  22. Harvey CJ, Blomley MJ, Eckersley RJ, et al. Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet. 2000;355:807–808
  23. Harvey CJ, Blomley MJ, Eckersley RJ, et al. Hepatic malignancies: improved detection with pulse-inversion US in late phase of enhancement with SHU 508A—early experience. Radiology. 2000;216:903–908
  24. Kim TK, Choi BI, Hong HS, et al. Improved imaging of hepatic metastases with delayed pulse inversion harmonic imaging using a contrast agent SHU 508A: preliminary study. Ultrasound Med Biol. 2000;26:1439–1444
  25. Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response—preliminary results. Radiology. 2000;217:558–563
  26. Kim TK, Choi BI, Han JK, et al. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology. 2000;216:411–417
  27. Meloni MF, Goldberg SN, Livraghi T, et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol. 2001;177:375–380
  28. von Herbay A, Vogt C, Haussinger D. Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions. J Ultrasound Med. 2002;21:1191–1200
  29. Wen YL, Kudo M, Zheng RQ, et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol. 2003;181:57–63
  30. Morimoto M, Shirato K, Sugimori K, et al. Contrast-enhanced harmonic gray-scale sonographic–histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. AJR Am J Roentgenol. 2003;181:65–69
  31. von Herbay A, Vogt C, Haussinger D. Differentiation between benign and malignant hepatic lesions: utility of color stimulated acoustic emission with the microbubble contrast agent Levovist. J Ultrasound Med. 2004;23:207–215
  32. Bryant TH, Blomley MJ, Albrecht T, et al. Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study. Radiology. 2004;232:799–809
  33. Dietrich CF, Ignee A, Trojan J, et al. Improved characterization of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut. 2004;53:401–405
  34. Kim CK, Choi D, Lim HK, et al. Therapeutic response assessment of percutaneous radio frequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol. 2005;56:66–73
  35. Maruyama H, Matsutani S, Okugawa H, et al. Microbubble disappearance-time is the appropriate timing for liver-specific imaging after injection of Levovist. Ultrasound Med Biol. 2006;32:1809–1815
  36. Joseph AE, Saverymuttu SH, Al-Sam S, et al. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43:26–31
  37. Kitamura S, Iishi H, Tatsuta M, et al. Liver with hypoechoic nodular pattern as a risk factor for hepatocellular carcinoma. Gastroenterology. 1995;108:1778–1784
  38. Tarao K, Hoshino H, Shimizu A, et al. Patients with ultrasonic coarse-nodular cirrhosis who are anti-hepatitis C virus-positive are at high risk for hepatocellular carcinoma. Cancer. 1995;75:1255–1262
  39. Shapiro RS, Wagreich J, Parsons RB, et al. Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography. AJR Am J Roentgenol. 1998;171:1203–1206
  40. Hann LE, Bach AM, Cramer LD, et al. Hepatic sonography: comparison between tissue harmonic and standard sonography techniques. AJR Am J Roentgenol. 1999;173:201–206
  41. Whittingham TA. Tissue harmonic imaging. Eur Radiol. 1999;9:S323–S326
  42. Harvey CJ, Albrecht T. Ultrasound of focal lesions. Eur Radiol. 2001;11:1578–1593
  43. Numata K, Isozaki T, Ozawa Y, et al. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma. AJR Am J Roentgenol. 2003;180:143–149
  44. Yu JS, Kim KW, Sung KB, et al. Small arterial-portal venous shunts: cause of pseudolesions at hepatic imaging. Radiology. 1997;203:737–742
  45. Kim TK, Choi BI, Han JK, et al. Nontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: two-phase spiral CT findings. Radiology. 1998;208:597–603
  46. Brancatelli G, Baron RL, Peterson MS, et al. Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation. AJR Am J Roentgenol. 2003;180:1007–1014
  47. Kudo M. Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis. 1999;19:297–309
  48. Hayashi M, Matsui O, Ueda K, et al. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology. 2002;225:143–149
  49. Bolondi L, Gaiani S, Celli N, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology. 2005;42:27–34
  50. Bruix J, Sherman M. Practice Guidelines Committee, American Association for the study of liver diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236
  51. Roncalli M, Roz E, Coggi G, et al. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implication for diagnosis and classification. Hepatology. 1999;30:1174–1178
  52. International Working Party . Terminology of nodular hepatocellular lesions. Hepatology. 1995;22:983–989
  53. Borzio M, Fargion S, Borzio F, et al. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol. 2003;39:208–214
  54. Tanaka M, Nakashima O, Wada Y, et al. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology. 1996;24:807–812
  55. Lim JH, Choi D, Cho SK, et al. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: Importance of Kupffer cell number. Radiology. 2001;220:669–676
  56. Krix M, Kiessling F, Essig M, et al. Low mechanical index contrast-enhanced ultrasound better reflects high arterial perfusion of liver metastases than arterial phase computed tomography. Invest Radiol. 2004;39:216–222
  57. Maruyama H, Matsutani S, Saisho H, et al. Real-time blood-pool images of contrast enhanced ultrasound with Definity in the detection of liver tumour nodules in the liver. Br J Radiol. 2005;78:512–518

PII: S0009-9260(07)00077-3

doi: 10.1016/j.crad.2006.11.025

Clinical Radiology
Volume 62, Issue 7 , Pages 668-675 , July 2007

Article Tools

* Image Usage & Resolution